120 related articles for article (PubMed ID: 38194619)
1. Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
Vidal GA; Jain N; Fisher A; Sheinson D; Lofgren KT; Ma E; Yu E; Comment L; Miksad R; Sincan M; Martin RL; Zuniga R; Daniel D
JCO Oncol Pract; 2024 Mar; 20(3):370-377. PubMed ID: 38194619
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.
Pittell H; Calip GS; Pierre A; Ryals CA; Altomare I; Royce TJ; Guadamuz JS
JAMA Netw Open; 2023 Jul; 6(7):e2322515. PubMed ID: 37477920
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US.
Islam JY; Braithwaite D; Zhang D; Guo Y; Tailor TD; Akinyemiju T
Cancer Med; 2023 Apr; 12(7):8567-8580. PubMed ID: 36533434
[TBL] [Abstract][Full Text] [Related]
4. Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Schwartzberg L; Daniel D; Vaena D; Slater D; Staszewski H; Fang B; Seneviratne L; Yu E; Price R; Szado T; Meyer CS; Shah A; Ma E
Future Oncol; 2023 Jun; 19(20):1397-1414. PubMed ID: 37318757
[TBL] [Abstract][Full Text] [Related]
5. Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
Sheinson DM; Wong WB; Meyer CS; Stergiopoulos S; Lofgren KT; Flores C; Adams DV; Fleury ME
JAMA Netw Open; 2021 Dec; 4(12):e2138219. PubMed ID: 34882180
[TBL] [Abstract][Full Text] [Related]
6. Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
Sheinson DM; Wong WB; Flores C; Ogale S; Gross CP
JCO Oncol Pract; 2021 Nov; 17(11):e1774-e1784. PubMed ID: 34043456
[TBL] [Abstract][Full Text] [Related]
7. Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer.
Matsuda H; Ogawa T; Sadatsuki Y; Tsujino T; Wada S; Kim SW; Hatanaka Y
Respir Investig; 2023 Jan; 61(1):61-73. PubMed ID: 36460584
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
Kang DW; Park SK; Yu YL; Lee Y; Lee DH; Kang S
ESMO Open; 2024 Jan; 9(1):102200. PubMed ID: 38194884
[TBL] [Abstract][Full Text] [Related]
9. Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study.
Paz-Ares L; Gondos A; Saldana D; Thomas M; Mascaux C; Bubendorf L; Barlesi F
Lung Cancer; 2022 May; 167():41-48. PubMed ID: 35397297
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Tumor Mutational Burden, Immunotherapy Use, and Outcomes Based on Genomic Ancestry in Non-Small-Cell Lung Cancer.
Brawley OW; Luhn P; Reese-White D; Ogbu UC; Madhavan S; Wilson G; Cox M; Ewing A; Hammer C; Richie N
JCO Glob Oncol; 2021 Sep; 7():1537-1546. PubMed ID: 34752134
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States.
Bruno DS; Hess LM; Li X; Su EW; Patel M
JCO Precis Oncol; 2022 Jun; 6():e2100427. PubMed ID: 35737912
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.
Lin Q; Paykin S; Halpern D; Martinez-Cardoso A; Kolak M
JAMA Netw Open; 2022 Mar; 5(3):e220984. PubMed ID: 35244703
[TBL] [Abstract][Full Text] [Related]
13. Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS
Clin Lung Cancer; 2021 Jan; 22(1):16-22.e1. PubMed ID: 33397584
[TBL] [Abstract][Full Text] [Related]
14. Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
Cui W; Milner-Watts C; O'Sullivan H; Lyons H; Minchom A; Bhosle J; Davidson M; Yousaf N; Scott S; Faull I; Kushnir M; Nagy R; O'Brien M; Popat S
Eur J Cancer; 2022 Aug; 171():44-54. PubMed ID: 35704974
[TBL] [Abstract][Full Text] [Related]
15. Generating Team-Based Strategies to Reduce Health Inequity in Cancer Care.
Moreo K; Sullivan S; Carter J; Heggen C
Prof Case Manag; 2023 Sep-Oct 01; 28(5):215-223. PubMed ID: 37487154
[TBL] [Abstract][Full Text] [Related]
16. Utilization Trends and Factors Associated With ROS1 Testing Among Patients With Advanced Non-small-cell Lung Cancer in US Community Practices.
Wong W; Wu N; Gupta R; Mansfield AS
Clin Lung Cancer; 2021 May; 22(3):e470-e480. PubMed ID: 32763067
[TBL] [Abstract][Full Text] [Related]
17. Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group.
Malapelle U; Donne AD; Pagni F; Fraggetta F; Rocco EG; Pasello G; Perrone G; Pepe F; Vatrano S; Pignata S; Pinto C; Pruneri G; Russo A; Soto Parra HJ; Vallone S; Marchetti A; Troncone G; Novello S
Crit Rev Oncol Hematol; 2024 Jan; 193():104217. PubMed ID: 38040072
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer.
Dalal AA; Guerin A; Mutebi A; Culver KW
J Med Econ; 2018 Jul; 21(7):649-655. PubMed ID: 29516752
[TBL] [Abstract][Full Text] [Related]
19. Measuring Racial Inequities In The Quality Of Care Across Oncology Practices In The US.
Keating NL; Landrum MB; Samuel-Ryals C; Sinaiko AD; Wright A; Brooks GA; Bai B; Zaslavsky AM
Health Aff (Millwood); 2022 Apr; 41(4):598-606. PubMed ID: 35377762
[TBL] [Abstract][Full Text] [Related]
20. Trial of Electronic Medical Record Integrated Next-Generation Sequencing Ordering in Veterans Affairs Cancer Care.
Stoeckle JH; Poland SG; Maynard H; Roman SD; Mettman D; Makarov DV; Sherman S; Becker DJ
JCO Precis Oncol; 2024 Apr; 8():e2300463. PubMed ID: 38691812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
